Literature DB >> 29911928

SAMHD1 modulates in vitro proliferation of acute myeloid leukemia-derived THP-1 cells through the PI3K-Akt-p27 axis.

Karthik M Kodigepalli1,2, Serena Bonifati1, Nagaraja Tirumuru1, Li Wu1,3,4.   

Abstract

Sterile alpha motif and HD domain-containing protein 1 (SAMHD1) is a mammalian dNTP hydrolase that acts as a negative regulator in the efficacy of cytarabine treatment against acute myeloid leukemia (AML). However, the role of SAMHD1 in AML development and progression remains unknown. We have reported that SAMHD1 knockout (KO) in the AML-derived THP-1 cells results in enhanced proliferation and reduced apoptosis, but the underlying mechanisms are unclear. Here we show that SAMHD1 KO in THP-1 cells increased PI3K activity and reduced expression of the tumor suppressor PTEN. Pharmacological inhibition of PI3K activity reduced cell proliferation specifically in SAMHD1 KO cells, suggesting that SAMHD1 KO-induced cell proliferation is mediated via enhanced PI3K signaling. However, PI3K inhibition did not significantly affect SAMHD1 KO-reduced apoptosis, implicating the involvement of additional mechanisms. SAMHD1 KO also led to enhanced phosphorylation of p27 at residue T157 and its mis-localization to the cytoplasm. Inhibition of PI3K activity reversed these effects, indicating that SAMHD1 KO-induced changes in p27 phosphorylation and localization is mediated via PI3K-Akt signaling. While SAMHD1 KO significantly enhanced THP-1 cell migration in vitro, SAMHD1 KO attenuated the ability of THP-1 cells to form subcutaneous tumors in xenografted immunodeficient mice. This effect correlated with significantly increased expression of tumor necrosis factor α (TNF-α) in tumors, which may suggest that TNF-α-mediated inflammation could account for the decreased tumorigenicity in vivo. Our findings implicate that SAMHD1 can regulate AML cell proliferation via modulation of the PI3K-Akt-p27 signaling axis, and that SAMHD1 may affect tumorigenicity by downregulating inflammation.

Entities:  

Keywords:  Akt; PI3K; PTEN; SAMHD1; cell proliferation; p27

Year:  2018        PMID: 29911928      PMCID: PMC6110597          DOI: 10.1080/15384101.2018.1480218

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  71 in total

1.  Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial.

Authors:  Deepa Sampath; Jorge Cortes; Zeev Estrov; Min Du; Zheng Shi; Michael Andreeff; Varsha Gandhi; William Plunkett
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

2.  With me or against me: Tumor suppressor and drug resistance activities of SAMHD1.

Authors:  Nikolas Herold; Sean G Rudd; Kumar Sanjiv; Juliane Kutzner; Ida Hed Myrberg; Cynthia B J Paulin; Thale Kristin Olsen; Thomas Helleday; Jan-Inge Henter; Torsten Schaller
Journal:  Exp Hematol       Date:  2017-05-11       Impact factor: 3.084

3.  SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.

Authors:  Hanna-Mari Baldauf; Xiaoyu Pan; Elina Erikson; Sarah Schmidt; Waaqo Daddacha; Manja Burggraf; Kristina Schenkova; Ina Ambiel; Guido Wabnitz; Thomas Gramberg; Sylvia Panitz; Egbert Flory; Nathaniel R Landau; Serkan Sertel; Frank Rutsch; Felix Lasitschka; Baek Kim; Renate König; Oliver T Fackler; Oliver T Keppler
Journal:  Nat Med       Date:  2012-11       Impact factor: 53.440

4.  PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer.

Authors:  Shyam Babu Prasad; Suresh Singh Yadav; Mitali Das; Arusha Modi; Soni Kumari; Lakshmi Kant Pandey; Sunita Singh; Satyajit Pradhan; Gopeshwar Narayan
Journal:  Cell Oncol (Dordr)       Date:  2015-03-28       Impact factor: 6.730

5.  Downregulation of SAMHD1 expression correlates with promoter DNA methylation in Sézary syndrome patients.

Authors:  Suresh de Silva; Feifei Wang; Timothy S Hake; Pierluigi Porcu; Henry K Wong; Li Wu
Journal:  J Invest Dermatol       Date:  2013-07-24       Impact factor: 8.551

6.  The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells.

Authors:  Elisa Franzolin; Giovanna Pontarin; Chiara Rampazzo; Cristina Miazzi; Paola Ferraro; Elisa Palumbo; Peter Reichard; Vera Bianchi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

Review 7.  p27Kip1 and human cancers: A reappraisal of a still enigmatic protein.

Authors:  Debora Bencivenga; Ilaria Caldarelli; Emanuela Stampone; Francesco Paolo Mancini; Maria Luisa Balestrieri; Fulvio Della Ragione; Adriana Borriello
Journal:  Cancer Lett       Date:  2017-07-05       Impact factor: 8.679

8.  PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.

Authors:  Incheol Shin; F Michael Yakes; Federico Rojo; Nah-Young Shin; Andrei V Bakin; Jose Baselga; Carlos L Arteaga
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

9.  SAMHD1 suppresses innate immune responses to viral infections and inflammatory stimuli by inhibiting the NF-κB and interferon pathways.

Authors:  Shuliang Chen; Serena Bonifati; Zhihua Qin; Corine St Gelais; Karthik M Kodigepalli; Bradley S Barrett; Sun Hee Kim; Jenna M Antonucci; Katherine J Ladner; Olga Buzovetsky; Kirsten M Knecht; Yong Xiong; Jacob S Yount; Denis C Guttridge; Mario L Santiago; Li Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-02       Impact factor: 11.205

10.  A central role for PI3K-AKT signaling pathway in linking SAMHD1-deficiency to the type I interferon signature.

Authors:  Changhoon Oh; Jeongmin Ryoo; Kiwon Park; Baek Kim; Michele B Daly; DongYeon Cho; Kwangseog Ahn
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

View more
  10 in total

1.  SAMHD1 inhibits epithelial cell transformation in vitro and affects leukemia development in xenograft mice.

Authors:  Karthik M Kodigepalli; Minghua Li; Serena Bonifati; Amanda R Panfil; Patrick L Green; Shan-Lu Liu; Li Wu
Journal:  Cell Cycle       Date:  2018-12-04       Impact factor: 4.534

2.  SAMHD1, positively regulated by KLF4, suppresses the proliferation of gastric cancer cells through MAPK p38 signaling pathway.

Authors:  Zhangming Chen; Zhe Jiang; Lei Meng; Ye Wang; Minggui Lin; Zhijian Wei; Wenxiu Han; Songcheng Ying; Aman Xu
Journal:  Cell Cycle       Date:  2022-06-07       Impact factor: 5.173

Review 3.  SAMHD1 Suppression of Antiviral Immune Responses.

Authors:  Shuliang Chen; Serena Bonifati; Zhihua Qin; Corine St Gelais; Li Wu
Journal:  Trends Microbiol       Date:  2018-10-15       Impact factor: 17.079

Review 4.  Dual roles of SAMHD1 in tumor development and chemoresistance to anticancer drugs.

Authors:  Zhangming Chen; Jie Hu; Songcheng Ying; Aman Xu
Journal:  Oncol Lett       Date:  2021-04-08       Impact factor: 2.967

5.  Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells.

Authors:  Tamara Rothenburger; Dominique Thomas; Yannick Schreiber; Paul R Wratil; Tamara Pflantz; Kirsten Knecht; Katie Digianantonio; Joshua Temple; Constanze Schneider; Hanna-Mari Baldauf; Katie-May McLaughlin; Florian Rothweiler; Berna Bilen; Samira Farmand; Denisa Bojkova; Rui Costa; Nerea Ferreirós; Gerd Geisslinger; Thomas Oellerich; Yong Xiong; Oliver T Keppler; Mark N Wass; Martin Michaelis; Jindrich Cinatl
Journal:  J Exp Clin Cancer Res       Date:  2021-10-12

6.  Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AML.

Authors:  Feifei Zhang; Jun Sun; Xiaofeng Tang; Yiping Liang; Quanhui Jiao; Bo Yu; Zhengzai Dai; Xuhui Yuan; Jiayu Li; Jinhua Yan; Zhiping Zhang; Song Fan; Min Wang; Haiyan Hu; Changhua Zhang; Xiao-Bin Lv
Journal:  Cell Death Dis       Date:  2022-07-08       Impact factor: 9.685

7.  Neutrophil extracellular traps accelerate vascular smooth muscle cell proliferation via Akt/CDKN1b/TK1 accompanying with the occurrence of hypertension.

Authors:  Xinhui Fang; Ling Ma; Yanfu Wang; Fang Ren; Yanqiu Yu; Zhengwei Yuan; Hongquan Wei; Haipeng Zhang; Yingxian Sun
Journal:  J Hypertens       Date:  2022-08-03       Impact factor: 4.776

Review 8.  Purine-Metabolising Enzymes and Apoptosis in Cancer.

Authors:  Marcella Camici; Mercedes Garcia-Gil; Rossana Pesi; Simone Allegrini; Maria Grazia Tozzi
Journal:  Cancers (Basel)       Date:  2019-09-12       Impact factor: 6.639

Review 9.  SAMHD1 Functions and Human Diseases.

Authors:  Si'Ana A Coggins; Bijan Mahboubi; Raymond F Schinazi; Baek Kim
Journal:  Viruses       Date:  2020-03-31       Impact factor: 5.048

10.  TRAF6 and TAK1 Contribute to SAMHD1-Mediated Negative Regulation of NF-κB Signaling.

Authors:  Constanza E Espada; Corine St Gelais; Serena Bonifati; Victoria V Maksimova; Michael P Cahill; Sun Hee Kim; Li Wu
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.